Radiation Adverse Outcome pathways (AOPs): examining priority questions from an international horizon-style exercise

References

• Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, Nichols JW, Russom CL, Schmieder PK, et al. 2010. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 29(3):730–741. doi:10.1002/etc.34
   PubMed Web of Science ®Google Scholar
• Azimzadeh O, Moertl S, Ramadan R, Baselet B, Laiakis EC, Sebastian S, Beaton D, Hartikainen JM, Kaiser JC, Beheshti A, et al. 2022. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease. Int J Radiat Biol. 98(12):1722–1751. doi:10.1080/09553002.2022.2110325
   PubMed Web of Science ®Google Scholar
• Azzam EI, Jay-Gerin JP, Pain D. 2012. Ionizing radiation-induced metabolic oxidative stress and prolonged cell injury. Cancer Lett. 327(1-2):48–60. doi:10.1016/j.canlet.2011.12.012
   PubMed Web of Science ®Google Scholar
• Bajard L, Adamovsky O, Audouze K, Baken K, Barouki R, Beltman JB, Beronius A, Bonefeld-Jørgensen EC, Cano-Sancho G, de Baat ML, et al. 2023. Application of AOPs to assist regulatory assessment of chemical risks - Case studies, needs and recommendations. Environ Res. 217:114650., doi:10.1016/j.envres.2022.114650
   PubMed Web of Science ®Google Scholar
• Ban N, Cléro E, Vaillant L, Zhang W, Hamada N, Preston D, Laurier D. 2022. Radiation detriment calculation methodology: summary of ICRP Publication 152. J Radiol Prot. 42(2), doi:10.1088/1361-6498/ac670d
   Web of Science ®Google Scholar
• Becker RA, Ankley GT, Edwards SW, Kennedy SW, Linkov I, Meek B, Sachana M, Segner H, Van Der Burg B, Villeneuve DL, et al. 2015. Increasing scientific confidencein adverse outcome pathways: Application of tailored Bradford-Hill considerations for evaluating weight of evidence. Regul Toxicol Pharmacol. 72(3):514–537. doi:10.1016/j.yrtph.2015.04.004
   PubMed Web of Science ®Google Scholar
• Beyer J, Petersen K, Song Y, Ruus A, Grung M, Bakke T, Tollefsen KE. 2014. Environmental risk assessment of combined effects in aquatic ecotoxicology: a discussion paper. Mar Environ Res. 96:81–91. doi:10.1016/j.marenvres.2013.10.008
   PubMed Web of Science ®Google Scholar
• Burtt JJ, Leblanc J, Randhawa K, Ivanova A, Rudd MA, Wilkins R, Azzam EI, Hecker M, Horemans N, Vandenhove H, et al. 2022. Radiation adverse outcome pathways (AOPs) are on the horizon: advancing radiation protection through an international Horizon-Style exercise. Int J Radiat Biol. 98(12):1763–1776. doi:10.1080/09553002.2022.2121439
   PubMed Web of Science ®Google Scholar
• Cao Y, Moe SJ, De Bin R, Tollefsen KE, Song Y. 2023. Comparison of piecewise structural equation modeling and Bayesian network for de novo construction of a quantitative adverse outcome pathway network. ALTEX. 40(2):287–298.
   PubMedGoogle Scholar
• Carrothers E, Appleby M, Lai V, Kozbenko T, Alomar D, Smith BJ, Hamada N, Hinton P, Ainsbury EA, Hocking R, et al. 2024. AOP report: Development of an adverse outcome pathway for deposition of energy leading to cataracts. Environ Mol Mutagen. doi:10.1002/em.22594. Epub ahead of print.
   Google Scholar
• Chauhan V, Said Z, Daka J, Sadi B, Bijlani D, Marchetti F, Beaton D, Gaw A, Li C, Burtt J, et al. 2019. Is there a role for the adverse outcome pathway framework to support radiation protection? Int J Radiat Biol. 95(2):225–232. doi:10.1080/09553002.2019.1532617
   PubMed Web of Science ®Google Scholar
• Chauhan V, Hamada N, Monceau V, Ebrahimian T, Adam N, Wilkins RC, Sebastian S, Patel ZS, Huff JL, Simonetto C, et al. 2021. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation. Int J Radiat Biol. 97(11):1516–1525. doi:10.1080/09553002.2021.1969466
   PubMed Web of Science ®Google Scholar
• Chauhan V, Sherman S, Said Z, Yauk CL, Stainforth R. 2021. A case example of a radiation-relevant adverse outcome pathway to lung cancer. Int J Radiat Biol. 97(1):68–84. doi:10.1080/09553002.2019.1704913
   PubMed Web of Science ®Google Scholar
• Chauhan V, Stricklin D, Cool D. 2021. The integration of the adverse outcome pathway framework to radiation risk assessment. Int J Radiat Biol. 97(1):60–67. doi:10.1080/09553002.2020.1761570
   PubMed Web of Science ®Google Scholar
• Chauhan V, Villeneuve D, Cool D. 2021. Collaborative efforts are needed among the scientific community to advance the adverse outcome pathway concept in areas of radiation risk assessment. Int J Radiat Biol. 97(6):815–823. doi:10.1080/09553002.2020.1857456
   PubMed Web of Science ®Google Scholar
• Chauhan V, Wilkins RC, Beaton D, Sachana M, Delrue N, Yauk C, O'Brien J, Marchetti F, Halappanavar S, Boyd M, et al. 2021. Bringing together scientific disciplines for collaborative undertakings: a vision for advancing the adverse outcome pathway framework. Int J Radiat Biol. 97(4):431–441. doi:10.1080/09553002.2021.1884314
   PubMed Web of Science ®Google Scholar
• Chauhan V, Beaton D, Hamada N, Wilkins R, Burtt J, Leblanc J, Cool D, Garnier-Laplace J, Laurier D, Le Y, et al. 2022. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research. Int J Radiat Biol. 98(12):1694–1703. doi:10.1080/09553002.2021.2020363
   PubMed Web of Science ®Google Scholar
• Chauhan V, Hamada N, Garnier-Laplace J, Laurier D, Beaton D, Tollefsen KE, Locke PA. 2022. Establishing a communication and engagement strategy to facilitate the adoption of the adverse outcome pathways in radiation research and regulation. Int J Radiat Biol. 98(12):1714–1721. doi:10.1080/09553002.2022.2086716
   PubMed Web of Science ®Google Scholar
• Chauhan V, Yu J, Vuong N, Haber LT, Williams A, Auerbach SS, Beaton D, Wang Y, Stainforth R, Wilkins RC, et al. 2023. Considerations for application of benchmark dose modeling in radiation research: workshop highlights. Int J Radiat Biol. 99(9):1320–1331. doi:10.1080/09553002.2023.2181998
   PubMedGoogle Scholar
• Clancy M, Correa D, Dworkin J, Niehaus P, Watney C, Williams H. 2023. Want to speed up scientific progress? First understand how science policy works. Nature. 620(7975):724–726. doi:10.1038/d41586-023-02602-9
   PubMed Web of Science ®Google Scholar
• Cool DA, Kase KR, Boice JD. 2019. NCRP Report No.180-management of exposure to ionizing radiation: NCRP radiation protection guidance for the United States. J Radiol Prot. 39(3):966–977. doi:10.1088/1361-6498/ab1826
   PubMed Web of Science ®Google Scholar
• Eidemüller M, Becker J, Kaiser JC, Ulanowski A, Apostoaei AI, Hoffman FO. 2023. Concepts of association between cancer and ionising radiation: accounting for specific biological mechanisms. Radiat Environ Biophys. 62(1):1–15. doi:10.1007/s00411-022-01012-1
   PubMed Web of Science ®Google Scholar
• Flanders WD. 2006. On the relationship of sufficient component cause models with potential outcome (counterfactual) models. Eur J Epidemiol. 21:847–853. doi:10.1007/s10654-006-9048-3
   Google Scholar
• Greenland S. 1999. Relation of probability of causation to relative risk and doubling dose: a methodologic error that has become a social problem. Am J Public Health. 89(8):1166–1169. doi:10.2105/ajph.89.8.1166
   PubMed Web of Science ®Google Scholar
• Guéguen Y, Frerejacques M. 2022. Review of knowledge of uranium-induced kidney toxicity for the development of an adverse outcome pathway to renal impairment. Int J Mol Sci. 23(8):4397. Apr 15 doi:10.3390/ijms23084397
   PubMed Web of Science ®Google Scholar
• Hamada N, Zablotska LB. 2023. New evidence for brain cancer risk after a single paediatric CT scan. Lancet Oncol. 24(1):2–3. Jan doi:10.1016/S1470-2045(22)00696-9
   PubMed Web of Science ®Google Scholar
• Hamada N. 2023. Noncancer effects of ionizing radiation exposure on the eye, the circulatory system and beyond: developments made since the 2011 ICRP statement on tissue reactions. Radiat Res. 200(2):188–216.
   PubMed Web of Science ®Google Scholar
• Hamada N, Maeda M, Otsuka K, Tomita M. 2011. Signaling pathways underpinning the manifestations of ionizing radiation-induced bystander effects. Curr Mol Pharmacol. 4(2):79–95. doi:10.2174/1874467211104020079
   PubMedGoogle Scholar
• Hauptmann M, Daniels RD, Cardis E, Cullings HM, Kendall G, Laurier D, Linet MS, Little MP, Lubin JH, Preston DL, et al. 2020. Epidemiological studies of low-dose ionizing radiation and cancer: Summary bias assessment and meta-analysis. J Natl Cancer Inst Monogr. 2020(56):188–200. Jul 1 Erratum in: J Natl Cancer Inst Monogr. 2023 May 4;2023(61):e1 doi:10.1093/jncimonographs/lgaa010
   PubMedGoogle Scholar
• Hauptmann M, Byrnes G, Cardis E, Bernier MO, Blettner M, Dabin J, Engels H, Istad TS, Johansen C, Kaijser M, et al. 2023. Brain cancer after radiation exposure from CT examinations of children and young adults: results from the EPI-CT cohort study. Lancet Oncol. 24(1):45–53. Jan doi:10.1016/S1470-2045(22)00655-6
   PubMed Web of Science ®Google Scholar
• ICRP. 2007. The 2007 recommendations of the International Commission on Radiological Protection. Oxford: Pergamon Press.
   Google Scholar
• ICRP. 2012. ICRP Statement on Tissue Reactions/Early and Late Effects of Radiation in Normal Tissues and Organs – Threshold Doses for Tissue Reactions in a Radiation Protection Context. ICRP Publication 118. Ann. ICRP 41(1/2).
   Google Scholar
• ICRP. 2021. Use of dose quantities in radiological protection. ICRP Publication 147. Ann. ICRP. 50(1).
   Google Scholar
• Jaylet T, Quintens R, Benotmane MA, Luukkonen J, Tanaka IB, 3rd, Ibanez C, Durand C, Sachana M, Azimzadeh O, Adam-Guillermin C, et al. 2022. Development of an Adverse Outcome Pathway for radiation-induced microcephaly via expert consultation and machine learning. Int J Radiat Biol. 98(12):1752–1762. doi:10.1080/09553002.2022.2110312
   PubMed Web of Science ®Google Scholar
• Jaylet T, Quintens R, Armant O, Audouze K. 2023. An integrative systems biology strategy to support the development of adverse outcome pathways (AOPs): a case study on radiation-induced microcephaly. Front Cell Dev Biol. 11:1197204. Jun 22 doi:10.3389/fcell.2023.1197204
   PubMed Web of Science ®Google Scholar
• Jornod F, Jaylet T, Blaha L, Sarigiannis D, Tamisier L, Audouze K. 2022. AOP-helpFinder webserver: a tool for comprehensive analysis of the literature to support adverse outcome pathways development. Bioinformatics. 38(4):1173–1175. doi:10.1093/bioinformatics/btab750
   PubMed Web of Science ®Google Scholar
• Kaiser JC, Blettner M, Stathopoulos GT. 2021. Biologically based models of cancer risk in radiation research. Int J Radiat Biol. 97(1):2–11. doi:10.1080/09553002.2020.1784490
   PubMed Web of Science ®Google Scholar
• Klokov D, Applegate K, Badie C, Brede DA, Dekkers F, Karabulutoglu M, Le Y, Rutten EA, Lumniczky K, Gomolka M. 2022. International expert group collaboration for developing an adverse outcome pathway to radiation induced leukaemia. Int J Radiat Biol. 98(12):1802–1815. doi:10.1080/09553002.2022.2117873
   PubMed Web of Science ®Google Scholar
• Kozbenko T, Adam N, Lai V, Sandhu S, Kuan J, Flores D, Appleby M, Parker H, Hocking R, Tsaioun K, et al. 2022. Deploying elements of scoping review methods for Adverse Outcome Pathway development: A space travel case example. Int J Radiat Biol. 98(12):1777–1788. doi:10.1080/09553002.2022.2110306
   PubMed Web of Science ®Google Scholar
• Krewski D, Acosta D, Andersen M, Anderson H, Bailar JC, Boekelheide K, Brent R, Charnley G, Cheung VG, Green S, et al. 2010. Toxicity testing in the 21st century: a vision and a strategy. J Toxicol Environ Health B Crit Rev. 13(2-4):51–138. doi:10.1080/10937404.2010.483176
   PubMed Web of Science ®Google Scholar
• Laurier D, Billarand Y, Klokov D, Leuraud K. 2023. The scientific basis for the use of the linear no-threshold (LNT) model at low doses and dose rates in radiological protection. J Radiol Prot. 43(2). doi:10.1088/1361-6498/acdfd7
   Google Scholar
• Laurier D, Rühm W, Paquet F, Applegate K, Cool D, Clement C, International Commission on Radiological Protection (ICRP). 2021. Areas of research to support the system of radiological protection. Radiat Environ Biophys. 60(4):519–530. doi:10.1007/s00411-021-00947-1
   PubMed Web of Science ®Google Scholar
• Leist M, Ghallab A, Graepel R, Marchan R, Hassan R, Bennekou SH, Limonciel A, Vinken M, Schildknecht S, Waldmann T, et al. 2017. Adverse outcome pathways: opportunities, limitations and open questions. Arch Toxicol. 91(11):3477–3505. doi:10.1007/s00204-017-2045-3
   PubMed Web of Science ®Google Scholar
• Little MP, Wakeford R, Borrego D, French B, Zablotska LB, Adams MJ, Allodji R, de Vathaire F, Lee C, Brenner AV, et al. 2018. Leukaemia and myeloid malignancy among people exposed to low doses (<100 mSv) of ionising radiation during childhood: a pooled analysis of nine historical cohort studies. Lancet Haematol. 5(8):e346–e358. Augdoi:10.1016/S2352-3026(18)30092-9
   PubMed Web of Science ®Google Scholar
• Little MP, Cahoon EK, Kitahara CM, Simon SL, Hamada N, Linet MS. 2020. Occupational radiation exposure and excess additive risk of cataract incidence in a cohort of US radiologic technologists. Occup Environ Med. 77(1):1–8. doi:10.1136/oemed-2019-105902
   PubMed Web of Science ®Google Scholar
• Little MP, Azizova TV, Richardson DB, Tapio S, Bernier MO, Kreuzer M, Cucinotta FA, Bazyka D, Chumak V, Ivanov VK, et al. 2023. Ionising radiation and cardiovascular disease: systematic review and meta-analysis. BMJ. 380:e072924. doi:10.1136/bmj-2022-072924
   PubMedGoogle Scholar
• Little MP, Wakeford R, Bouffler SD, Abalo K, Hauptmann M, Hamada N, Kendall GM. 2022. Review of the risk of cancer following low and moderate doses of sparsely ionising radiation received in early life in groups with individually estimated doses. Environ Int. 159:106983. doi:10.1016/j.envint.2021.106983
   PubMed Web of Science ®Google Scholar
• Matsumoto H, Tomita M, Otsuka K, Hatashita M, Hamada N. 2011. Nitric oxide is a key molecule serving as a bridge between radiation-induced bystander and adaptive responses. Curr Mol Pharmacol. 4(2):126–134. doi:10.2174/1874467211104020126
   PubMedGoogle Scholar
• Moe SJ, Wolf R, Xie L, Landis WG, Kotamäki N, Tollefsen KE. 2021. Quantification of an adverse outcome pathway network by Bayesian regression and Bayesian network modeling. Integr Environ Assess Manag. 17(1):147–164. doi:10.1002/ieam.4348
   PubMed Web of Science ®Google Scholar
• NCRP. 2018. Implications of Recent Epidemiologic Studies for the Linear-Nonthreshold Model and Radiation Protection. NCRP Commentary No. 27, National Council on Radiation Protection and Measurements, 2018.
   Google Scholar
• NCRP. 2020. Approaches for integrating information from radiation biology and epidemiology to enhance low-dose health risk assessment. NCRP Report No. 186, National Council on Radiation Protection and Measurements, 2020.
   Google Scholar
• NRC. 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC: The National Academies Press. doi:10.17226/11970
   Google Scholar
• OECD. 2018. Users’ Handbook supplement to the Guidance Document for developing and assessing Adverse Outcome Pathways. OECD Series on Adverse Outcome Pathways, No. 1, Organisation for Economic Co-operation and Development Publishing, Paris, France.
   Google Scholar
• OECD. 2021. Guidance document for the scientific review of adverse outcome pathways. Series on Testing and Assessment, No. 344. Series on Adverse Outcome Pathways, No. 20. ENV/CBC/MONO. 22, Organisation of Economic Co-operation and Development, Paris, France.
   Google Scholar
• Preston RJ. 2017. Can radiation research impact the estimation of risk? Int J Radiat Biol. Oct93(10):1009–1014. doi:10.1080/09553002.2017.1290848
   PubMed Web of Science ®Google Scholar
• Richardson DB, Leuraud K, Laurier D, Gillies M, Haylock R, Kelly-Reif K, Bertke S, Daniels RD, Thierry-Chef I, Moissonnier M, et al. 2023. Cancer mortality after low dose exposure to ionising radiation in workers in France, the United Kingdom, and the United States (INWORKS): cohort study. BMJ. 382:e074520. doi:10.1136/bmj-2022-074520
   PubMedGoogle Scholar
• Rothman KJ, Greenland S. 2005. Causation and causal inference in epidemiology. Am J Public Health. 95 Suppl 1:S144–S50. doi:10.2105/AJPH.2004.059204
   PubMed Web of Science ®Google Scholar
• Rühm W, Woloschak GE, Shore RE, Azizova TV, Grosche B, Niwa O, Akiba S, Ono T, Suzuki K, Iwasaki T, et al. 2015. Dose and dose-rate effects of ionizing radiation: a discussion in the light of radiological protection. Radiat Environ Biophys. 54(4):379–401. doi:10.1007/s00411-015-0613-6
   PubMed Web of Science ®Google Scholar
• Rühm W, Laurier D, Wakeford R. 2022. Cancer risk following low doses of ionising radiation - Current epidemiological evidence and implications for radiological protection. Mutat Res Genet Toxicol Environ Mutagen. 873:503436. doi:10.1016/j.mrgentox.2021.503436
   PubMed Web of Science ®Google Scholar
• Sabolić I. 2006. Common mechanisms in nephropathy induced by toxic metals. Nephron Exp. Nephrol. 104:107–114.
   Web of Science ®Google Scholar
• Salbu B, Teien HC, Lind OC, Tollefsen KE. 2019. Why is the multiple stressor concept of relevance to radioecology? Int J Radiat Biol. 95(7):1015–1024. doi:10.1080/09553002.2019.1605463
   PubMed Web of Science ®Google Scholar
• Seidle T, Stephens ML. 2009. Bringing toxicology into the 21st century: a global call to action. Toxicol in Vitro. 23(8):1576–1579. doi:10.1016/j.tiv.2009.06.012
   PubMed Web of Science ®Google Scholar
• Sherman S, Said Z, Sadi B, Yauk C, Beaton D, Wilkins R, Stainforth R, Adam N, Chauhan V. 2023. Adverse Outcome Pathway on deposition of energy leading to lung cancer, OECD Series on Adverse Outcome Pathways, No. 32, OECD Publishing, Paris. doi:10.1787/a8f262c2-en
   Google Scholar
• Simonetto C, Kaiser JC, van den Bogaard VAB, Langendijk JA, Crijns APG. 2022. Breast Cancer Radiation Therapy and the Risk of Acute Coronary Events: Insights from a Process-Oriented Model. Int J Radiat Oncol Biol Phys. 114(3):409–415. doi:10.1016/j.ijrobp.2022.06.082
   PubMed Web of Science ®Google Scholar
• Song Y, Xie L, Lee Y, Tollefsen KE. 2020. De novo development of a quantitative adverse outcome pathway (qAOP) network for ultraviolet B (UVB) radiation using targeted laboratory tests and automated data mining. Environ Sci Technol. 54(20):13147–13156. doi:10.1021/acs.est.0c03794
   PubMed Web of Science ®Google Scholar
• Song Y, Kamstra JH, Cao Y, Asselman J, Anglès d‘Auriac M, Friberg N. 2021. High-throughput analyses and Bayesian network modeling highlight novel epigenetic Adverse Outcome Pathway networks of DNA methyltransferase inhibitor mediated transgenerational effects. J Hazard Mater. 408:124490. Apr 15 doi:10.1016/j.jhazmat.2020.124490
   PubMed Web of Science ®Google Scholar
• Stainforth R, Schuemann J, McNamara AL, Wilkins RC, Chauhan V. 2021. Challenges in the quantification approach to a radiation relevant adverse outcome pathway for lung cancer. Int J Radiat Biol. 97(1):85–101. doi:10.1080/09553002.2020.1820096
   PubMed Web of Science ®Google Scholar
• Svingen T, Villeneuve DL, Knapen D, Panagiotou EM, Draskau MK, Damdimopoulou P, O'Brien JM. 2021. A Pragmatic Approach to Adverse Outcome Pathway Development and Evaluation. Toxicol Sci. 184(2):183–190. doi:10.1093/toxsci/kfab113
   PubMed Web of Science ®Google Scholar
• Tanabe S, Beaton D, Chauhan V, Choi I, Danielsen P, Delrue N, Esterhuizen M, Filipovska J, FitzGerald R, Fritsche E. 2022. Report of the 1st and 2nd mystery of reactive oxygen species conferences. ALTEX. 39(2):336–338. doi:10.14573/altex.2203011
   Google Scholar
• Tanabe S, O'Brien J, Tollefsen KE, Kim Y, Chauhan V, Yauk C, Huliganga E, Rudel RA, Kay JE, Helm JS, et al. 2022. Reactive oxygen species in the adverse outcome pathway framework: towards creation of harmonized consensus key events. Front Toxicol. 4:887135. doi:10.3389/ftox.2022.887135
   PubMedGoogle Scholar
• Thaulow J, Song Y, Lindeman LC, Kamstra JH, Lee Y, Xie L, Aleström P, Salbu B, Tollefsen KE. 2020. Epigenetic, transcriptional and phenotypic responses in Daphnia magna exposed to low-level ionizing radiation. Environ Res. 190:109930. doi:10.1016/j.envres.2020.109930
   PubMed Web of Science ®Google Scholar
• Tollefsen KE, Alonzo FR, Beresford NA, Brede DA, Dufourcq-Sekatcheff E, Gilbin R, Horemans N, Hurem S, Laloi P, Maremonti E, et al. 2022. Adverse outcome pathways (AOPs) for radiation-induced reproductive effects in environmental species: state of science and identification of a consensus AOP network. Int J Radiat Biol. 98(12):1816–1831. doi:10.1080/09553002.2022.2110317
   PubMed Web of Science ®Google Scholar
• UNSCEAR. 2010. Report of the United Nations Scientific Committee on the Effects of Atomic Radiation: 57th Session: Summary of Low_Dose Radiation Effects on Health. UNSCEAR; New York NY, USA: 2010.
   Google Scholar
• UNSCEAR. 2021. Annex C. Biological mechanisms relevant for the inference of cancer risks from low-dose and low-dose-rate radiation UNSCEAR 2020/2021 Report (Vienna: UNSCEAR).
   Google Scholar
• Xie L, Gomes T, Solhaug KA, Song Y, Tollefsen KE. 2018. Linking mode of action of the model respiratory and photosynthesis uncoupler 3,5-dichlorophenol to adverse outcomes in Lemna minor. Aquat Toxicol. 197:98–108. doi:10.1016/j.aquatox.2018.02.005
   PubMed Web of Science ®Google Scholar
• Xie L, Song Y, Petersen K, Solhaug KA, Lind OC, Brede DA, Salbu B, Tollefsen KE. 2022. Ultraviolet B modulates gamma radiation-induced stress responses in Lemna minor at multiple levels of biological organisation. Sci Total Environ. 846:157457. doi:10.1016/j.scitotenv.2022.157457
   PubMed Web of Science ®Google Scholar
• Yu J, Tu W, Payne A, Rudyk C, Cuadros Sanchez S, Khilji S, Kumarathasan P, Subedi S, Haley B, Wong A, et al. 2022. Adverse Outcome Pathways and Linkages to Transcriptomic Effects Relevant to Ionizing Radiation Injury. Int J Radiat Biol. 98(12):1789–1801. doi:10.1080/09553002.2022.2110313
   PubMed Web of Science ®Google Scholar